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did not differ between the studied groups, but proportion of
hypertension among controls was higher compared to the
patients with CRC (85.3% vs 69.6% p = 0.002).
Conclusions: In studied sample, we did not found the differ-
ences in the values of anthropometric indicators of metabolic
syndrome, cholesterol, HDL cholesterol, triglycerides and glucose
between patients with colorectal cancer and control. Systolic and
diastolic blood pressure as well as hypertension frequency were
significantly lower in CRC group than in the control group. Fur-
ther analysis including stage and localization of CRC is required.
The HAPIEE project is supported by Wellcome Trust
(WT081081AIA).
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The purpose of the study was to access pattern of microRNA
expression in tissue of precancerous lesions and larynx cancer.
A total of 25 people with a diagnosis of dysplasia II–III (n = 10),
control group (dysplasia 0, n = 15) and larynx cancer patients
(n = 46) were examined. Fresh frozen biopsies and adjacent nor-
mal epithelium were used. The diagnosis was verified by histol-
ogy. All qRT-PCR data were analyzed using the Pfaffl analysis.
Multiplex RT-PCR on miRNA templates were performed as
described by Chen et al. (2005). TaqMan miRNA assays (Iyevleva
et al., 2012) were used to quantify expression of mature miRNAs
of interest (miR-18a, -21, -155, -200a, -200c, -205, -221, -494). Data
were analyzed using Welsh t-test with a 5% FDR correction.
According to our results, aberrant expression of some miRNAs
was showed. There was no significant differences in miRNA
expression in a total group (n = 25) although a trend towards over-
expression of oncogenic miRNA-21 and -155 according to severity
of dysplastic changes in a tissue were present. Detailed analysis
showed significant overexpression of that miRNAs as well as
miRNA-200c and -205 in a group of dysplasia II- III against control
group (15 vs 10, p = 0.019, p = 0.045 and p = 0.020, p = 0.038, respec-
tively) but these results did not meet 5% FDR correction.
Data showed overexpression of the same microRNA (-205,
-155, -200 and -21) in larynx cancer patients compared to control
group (46 vs 15, p = 0.0002, p = 0.008, p = 0.009, p = 0.013, respec-
tively). It should be pointed that microRNA pattern both in larynx
cancer and patients with dysplasia II-III was very close showing
similarity of these groups at molecular level. Frequency of cases
with microRNA-205 overexpression was 2.98 times higher in can-
cer patients than in those who had no malignant transformation
(CI 95%, 1.41–16.26, p = 0.007). Data showed that up regulation of
microRNA-205 could be a marker of disease progression
(OR = 4.79). Three other microRNAs did not show any promising
results as biomarkers of cancer progression but data obtained
has interesting fundamental value.
These miRs (-21, -155, -205 and -200c) are known to be regula-
tors of processes that play an emergent role in carcinogenesis and
our results obtained in vivo highlight and expand knowledge
about some aspects of larynx cell transformation. Data suggest
that miRNAs changing its expression according to dysplasia
progress and could be important players in complex process of
carcinogenesis as well as could be potential markers of disease
progression.
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The purpose of the study was to assess parameters of
local cellular immunity, expression of apoptosis-controlling
proteins and some other receptors in various molecular sub-
types of breast cancer (BC) with different clinical course and
prognosis.
Materials and methods: 100 BC patients aged 30–76 years (59
± 3.4) were recruited. Tissues of tumor and peritumoral area were
homogenized by MediMachine, subset contents of T, B,
NK-lymphocytes were estimated by flow cytometer FACS CantoII.
Percentage of lymphocytes expressing CD3, CD4, CD8, CD19,
CD16/56, were counted from total amount of CD45+ lymphocytes.
Sections of paraffin-embedded blocks were studied by immuno-
histochemical method with polyvalent HRP-DAB detection sys-
tem. Staining was performed using Thermo Scientific
autostainer. Tumor was considered p53-positive when >25% of
tumor cell nuclei were positively stained, and bcl-2-positive when
>25% of cells showed specific cytoplasmic staining. Expression of
E-cadherin was assessed by the number of cells with positive
membrane expression of this marker, taking into account inten-
sity of the reaction. Expression of topoisomerase 2a and androgen
receptors was assessed by the number of tumor cells with
positive nuclear expression of these markers; number of stained
nuclei per 100 nuclei in 3 fields of view was counted.
Results: Some differences characterizing tumor cells of molec-
ular breast cancer subtypes were found. Tumor tissue contained
higher amount of T-lymphocytes than blood (85.9 ± 2.36% vs
60.1 ± 4.5%, P < 0.05) predominantly CD3+CD8+ cells (34.0 ± 1.9%
vs 20.3 ± 5.36%, P < 0.05) but lower percentage of B- and
NK-cells. In tissue of peritumoral area amounts of CD3+ and
CD3+CD8+ cells were also higher, while CD19+ level was lower
than in blood. In the same samples content of CD3+CD4+ was
lower and amount of NK-cells was higher than in tumor tissue.
Triple- negative subtype was characterized by maximal content
of CD3+ lymphocytes (92.2 ± 1.4%), luminal A contained the high-
est amount of CD3+CD16/56+ cells (10.6 ± 1.73%) vs luminal B
(4.34 ± 1.27%) and triple-negative (4.13 ± 1.63%). Her2+ neu BC
demonstrated high amount of NK-cells in peritumoral area but
not in tumor.
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p53 overexpression was equally often recorded in luminal B
and Her2+ subtypes of BC and slightly less frequently in
triple-negative subtype. Accumulation of p53 was 2 times less fre-
quently detected in luminal A subtype in comparison with triple -
negative cancer and 2.5 and 2.7 times less frequently in compar-
ison with luminal B and Her2+ BC, respectively. Study of bcl-2
expression showed reducing the frequency of positive tumor cell
staining in dependence on the receptor status of tumor: positive
cases were several times less frequent in triple-negative and
Her2+ subtypes in comparison with luminal A and B subtypes.
Luminal A subtype was characterized by the minimal p53,
topoisomerase 2a and androgen receptor expression and maxi-
mal expression of bcl-2 and E-cadherin. Luminal B subtype
showed a high expression of p53, bcl-2 and androgen receptors
and moderate expression of topoisomerase 2a and E-cadherin.
High expression of topoisomerase 2a, low expression of androgen
receptors and moderate expression of E- cadherin were registered
in triple-negative BC. The maximal expression of topoisomerase
2a and p53, as well as low expression of bcl-2 and E-cadherin,
was observed in Her2+ subtype.
Conclusions: CD8+ T-lymphocytes dominate in tumor tissue of
BC. Besides, tumor tissue of luminal A BC contains more NK-cells
than other subtypes. A number of differences in expression of
apoptosis-controlling proteins was observed in various molecular
subtypes of breast cancer. Luminal A BC was noted for the mini-
mal p53 expression and maximal bcl-2expression. Luminal B sub-
type had a high p53 and bcl- 2 expression. In Her2+ BC p53
expression was maximal and bcl-2 expression was low. The
described differences allow assessing molecular subtypes of
breast cancer and predicting the disease course from previously
unexplored perspectives.
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Background: Women’s reproductive health is significantly
determined by the relative constancy of the vaginal microbiota
(Ravel et al., 2011). Change of its qualitative and quantitative
composition is regarded as an edge with pathology of the condi-
tion with extremely diverse effects: from decreasing the quality
of life to enhancing the carcinogenic risks induced by anaerobic
bacteria metabolites (Mavzyutov et al., 2007). It was shown that
vaginal microbiota changes typical for bacterial vaginosis (BV)
are accompanied by similar changes in the CC microbiota (Smith
et al., 2014) that is associatedwith an increased risk of HIV, herpes
virus type 2, HPV, and neoplasia contamination (Borgdorff et al.,
2014).
Purpose of the study: To identify the bacteria types that influ-
ence the most significant changes in cytological patterns of the
CC in women with BV.
Materials and methods: To identify cytological characteristics
of the inflammatory process in the CC associated with BV and
quantitative species-specific changes in cervical microbiota,
cervical scrapings of 122 women (aged 18–45) were studied with
LC (Krjukova, 2008) and real-time PCR (‘‘Femoflor 16”, Russia).
Results: Following the cytological characteristics of the cellular
composition (abs.), presence of columnar epithelium, state of cell
nuclei, nuclear size, chromatin state, number of nuclei in the cell
(abs.Val.), existence and nature of nuclear changes, changes of the
cell shape, vacuolization of cytoplasm, cytoplasm clearing, cell
cytolysis, signs of keratinization, changes of cell size, increased
nuclear-cytoplasmic ratio and other factors, the women were
divided into 2 groups. The first group consisted of women with
cervicitis without vaginosis, and the other group- with cervicitis
associated with BV. Quantitative molecular genetic studies have
shown that in the cervicitis associated with BV, significantly
higher values were characterized by total bacterial mass and the
scraping content of Gardnerella vaginalis/Prevotella bivia/Porphy-
romonas spp., Sneathia spp./Leptotrihia spp./Fusobacterium spp.,
Megasphaera spp./Veillonella spp./Dialister spp., Mobiluncus
spp./Corynebacterium spp., Lachnobacterium spp./Clostridium spp.,
Peptostreptococcus spp., Atopobium vaginae and Ureaplasma spp.
However, the concentration of Enterobacteriaceae and Myco-
plasma hominis in cervicitis not accompanied and not associated
with BVwas not significantly different. According to LC, in cervici-
tis associated with BV, the test material contained statistically
significant (p < 0.05) large quantities of surface epithelial cells,
leukocytes, macrophages, ‘‘key” cells and small rod-shaped bacte-
ria, but cytolysis and ectomorphy bacteria were not found.
According to factor analysis of quantitative PCR and LC, the most
significant was positive relationship between increasing concen-
tration of Lachnobacterium spp./Clostridium spp., Mobiluncus spp./
Corynebacterium spp., Peptostreptococcus spp.,A. vaginae Mycoplasma
hominis and detection of small rod-shaped bacterial flora and the
‘‘key” cells; and negative – with the identification of accommoda-
tion bacteria. The increase of Ureaplasma spp. in the cervical
scraping in connection with BV was accompanied by increase of
cells without increase of macrophages. The combined increase
of leukocytes and macrophages was accompanied by a significant
reduction of surface epithelium cells.
Conclusion: 1. Cytological pattern of inflammation during BV
differs from the pattern of cervical inflammation not associated
with BV; 2. Quantitative changes of the CC microbiota in BV
detected by PCR are correlated with the cytological features of
the inflammation pattern; 3. The influence of inflammation
caused by quantitative changes in the CC microbiota on the
increased risk of neoplastic processes is not excluded.
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Matrix metalloproteinase-9 and -13 as regulators of TGF-b-the signal
transduction pathway in melanoma tumor cells
EJC SUPPLEMENTS 13 (2015) 1–75 41
